Vertex Pharmaceuticals (VRTX) Change in Acquisitions & Divestments (2009 - 2026)

Vertex Pharmaceuticals' Change in Acquisitions & Divestments history runs 18 years deep, the most recent figure standing at $2.2 billion for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 34.9% year-over-year to $2.2 billion; the TTM figure through Mar 2026 stood at $6.5 billion (up 597.76% YoY), while the FY2025 annual figure was $5.9 billion, changed N/A from the prior year.
• Change in Acquisitions & Divestments was $2.2 billion for Q1 2026 at Vertex Pharmaceuticals, up from $1.1 billion in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $2.2 billion in Q1 2026 to a low of -$3.0 billion in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $546.8 million across 5 years, with a median of $710.5 million in 2024.
• Biggest YoY gain for Change in Acquisitions & Divestments was 2522.17% in 2024; the steepest drop was 471.48% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at -$129.7 million in 2022, then tumbled by 305.47% to -$525.9 million in 2023, then tumbled by 471.48% to -$3.0 billion in 2024, then soared by 136.33% to $1.1 billion in 2025, then soared by 102.34% to $2.2 billion in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $2.2 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.